Covered recipient · General Payments record
NATASHA ANN WELKER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Obstetrics
General Payments · PY2020–2024
$1,392.19
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.48 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sage Therapeutics, Inc. | $110.43 | 4 |
| ABBVIE INC. | $75.43 | 3 |
| PFIZER INC. | $33.65 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $32.23 | 3 |
| CooperSurgical, Inc. | $19.64 | 1 |
| Organon LLC | $17.59 | 1 |
| Hologic Sales and Service, LLC | $16.27 | 1 |
| Novo Nordisk AS | $14.93 | 1 |
| Amgen Inc. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.59 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108395019 | CMS |
| ABBVIE INC. | $19.89 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108395021 | CMS |
| ABBVIE INC. | $22.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108395023 | CMS |
| Amgen Inc. | $14.31 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117412547 | CMS |
| CooperSurgical, Inc. | $19.64 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150783832 | CMS |
| Hologic Sales and Service, LLC | $16.27 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084869089 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $30.04 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670887 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $0.72 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670889 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $1.47 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670891 | CMS |
| Novo Nordisk Inc | $14.93 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570822 | CMS |
| Organon Llc | $17.59 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238439 | CMS |
| PFIZER INC. | $20.33 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625711 | CMS |
| PFIZER INC. | $13.32 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131849405 | CMS |
| Sage Therapeutics, Inc. | $28.57 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120405014 | CMS |
| Sage Therapeutics, Inc. | $21.61 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120405012 | CMS |
| Sage Therapeutics, Inc. | $26.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120399862 | CMS |
| Sage Therapeutics, Inc. | $33.37 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120396223 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.